Latest Capital Raise News

WAM Active Limited has successfully closed an oversubscribed entitlement offer, raising $70.7 million and increasing its asset base by over 84%, enhancing liquidity and market presence.

Tartana Minerals is advancing its strategic metals portfolio in Far North Queensland with a robust 2026 drilling program and ongoing copper sulphate production, aiming to unlock significant resource potential across silver, gold, and copper assets.

Celsius Resources has raised A$9.3 million through a well-supported institutional placement, strengthening its balance sheet to advance the financing and early development of its flagship MCB copper-gold project in the Philippines.

JCurve Solutions has reported a strong half-year performance, returning to profitability with a 32% increase in revenue to $7.02 million, driven by higher NetSuite commissions and a strategic shift towards larger customers.

VEEM Limited reports half-year revenue close to guidance with improved cash flow, offset by a significant $24.8 million non-cash impairment tied to its gyro product upgrade. The transition to the new Mark III gyro design has temporarily stalled sales as customers await delivery.

Barton Gold Holdings has distributed over $640,000 in Junior Minerals Exploration Incentive tax credits to investors from its June 2025 placement, enhancing returns amid strong exploration activity.

Deal headlines and big drill hits shared the stage with a brutal sell-off in a handful of tiny raisings. The week’s biggest winners were backed by clear news; the biggest losers showed what happens when buyers vanish after a halt.

Big gains hit wealth platforms while Zip swung the other way as early optimism didn’t stick. Dividends and buy-backs kept coming, but investors still punished stocks where the next step looks unclear.

Small caps stole the spotlight, with a handful of stocks doubling on deal news and early-stage project updates. Large miners were steadier, but even they couldn’t fully escape the week’s sharp gap moves.

Two capital raisings and one brutal reset set the tone, even as several companies posted clean growth or strong clinical updates. Radiopharmaceuticals kept delivering good news, but investors still punished supply-chain and cash needs fast.

FortifAI’s funding and big claims around faster AI data processing drove the week’s loudest move, while two small caps jumped on price queries. Elsewhere, results season rewarded clear recurring revenue growth, but punished gaps where early buying didn’t stick.

Aurora Labs reported a 15% revenue decline and a 12% increase in net loss for H1 2026, yet marked a strategic breakthrough with its first defence propulsion order and a successful $5.5 million capital raise.